On the evening of February 22, Longjin pharmaceutical (002750) announced that the company's breviscapine was obtained the United States GRAS (Generally Recognized as Safe) expert committee affirmation, it can be as a food additive use dietary supplememt. This certification was valued by the GRAS expert committee hired by the American cooperative party. They made a comprehensive evaluation and analysis on the information on the ingredients, manufacturing process, pharmacology, toxicology and other aspects provided by the company. Experts agree that breviscapine is a safe food additive and dietary supplement that can be used as food and dietary supplement product. The recommended intake of breviscapine as a food ingredient is 84 mg/day and 200 mg/day as a dietary supplement.

According to the announcement, brezhapine has been recognized by the American GRAS expert committee, marks the recognition of product quality and safety. It can be exported to the United States and other international markets that recognize the American GRAS certification are sold as food and dietary supplement raw materials, which is expected to have a positive impact on the company's performance. At present, the company has not yet signed the breviscapine export contract.